With this expansion, the company is now eligible to provide a range of microbiology testing services such as bacteriology, mycobacteriology and testing of microbioterrorism pathogens.
The laboratory also provides extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and single nucleotide polymorphism analysis.
PPD Global Central Labs senior vice president Elena Logan said strengthening their microbiology capabilities demonstrates PPD’s commitment to deliver a range of quality global central laboratory services and builds on their fully integrated clinical research and development expertise across all areas of infectious diseases.